The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A germline deletion of p14ARF but not CDKN2A in a melanoma-neural system tumour syndrome family
Abstract
The melanoma-astrocytoma syndrome is characterized by a dual predisposition to melanoma and neural system tumours, commonly astrocytoma. Germline deletions of the region on 9p21 containing the CDKN2A and CDKN2B genes and CDKN2A exon 1beta have been reported in kindreds, implicating contiguous tumour suppressor gene deletion as a cause of this syndrome. We describe a family characterized by multiple melanoma and neural cell tumours segregating with a germline deletion of the p14(ARF)-specific exon 1beta of the CDKN2A gene. This deletion does not affect the coding or minimal promoter sequences of either the CDKN2A or CDKN2B genes. Our results are consistent with either: (i) loss of p14(ARF) function being the critical abnormality associated with this syndrome, rather than contiguous loss of both the CDKN2A and CDKN2B genes as suggested previously; or (ii) disruption of expression of p16 by mechanisms as yet unknown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Nucleolar Arf sequesters Mdm2 and activates p53
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-210 · Cited by 627
Interaction between the retinoblastoma protein and the oncoprotein MDM2
Xiao, Z.-X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J., Sellers, W. R., & Livingston, D. M. (1995) · Nature · doi:10.1038/375694a0 · Cited by 587
Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E., & Collins, V. P. (1993) · PubMed · Cited by 560
Complex structure and regulation of the P16 (MTS1) locus.
Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H. L., Parry, D., Peters, G., & Kamb, A. (1995) · PubMed · Cited by 383
Robertson, K. D., & Jones, P. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6457 · Cited by 352
Mao, L., Merlo, A. U., Bedi, G. C., Shapiro, G. I., Edwards, C. D., Rollins, B. J., & Sidransky, D. (1995) · PubMed · Cited by 329
The INK4 family of cell cycle inhibitors in cancer
Roussel, M. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202998 · Cited by 322
p16INK4A and p19ARF act in overlapping pathways in cellular immortalization
Carnero, A., Hudson, J. D., Price, C. M., & Beach, D. H. (2000) · Nature Cell Biology · doi:10.1038/35004020 · Cited by 279
Quelle, D. E., Cheng, M., Ashmun, R. A., & Sherr, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.669 · Cited by 220
FitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Unsal, H., O'Neill, E., Koh, J., Finkelstein, D. M., Isselbacher, K. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8541 · Cited by 200
p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer
Williamson, M. P., Elder, P. A., Shaw, M. E., Devlin, J., & Knowles, M. A. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.9.1569 · Cited by 179
Bahuau, M., Vidaud, D., Jenkins, R. B., Bièche, I., Kimmel, D. W., Assouline, B., Smith, J. S., Alderete, B. E., Cayuela, J., Harpey, J. P., et al. (1998) · PubMed · Cited by 163
Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice
Zurawel, R. H., Allen, C., Wechsler‐Reya, R. J., Scott, M. P., & Raffel, C. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200005)28:1<45::aid-gcc6>3.0.co;2-f · Cited by 155
Platz, A., Hansson, J., Månsson‐Brahme, E., Lagerlöf, B., Linder, S., Ringborg, U. K., Lundqvist, E., Sevigny, P., & Inganäs, M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.10.697 · Cited by 153
Laurendeau, I., Bahuau, M., Vodovar, N., Larramendy, C., Olivi, M., Bièche, I., Vidaud, M., & Vidaud, D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.982 · Cited by 149
Germline Mutations of the CDKN2 Gene in UK Melanoma Families
Harland, M., Meloni, R., Gruis, N. A., Pinney, E., Brookes, S., Spurr, N. K., Frischauf, A., Bataille, V. A., Peters, G., Cuzick, J. M., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2061 · Cited by 143
Genomic Alterations of the p19ARF Encoding Exons in T-Cell Acute Lymphoblastic Leukemia
Gardie, B., Cayuela, J., Martini, S., & Sigaux, F. (1998) · Blood · doi:10.1182/blood.v91.3.1016 · Cited by 112
Deletion mapping of chromosome region 9p21-p22 surrounding theCDKN2 locus in melanoma
Ohta, M., Berd, D., Shimizu, M., Nagai, H., Cotticelli, M., Mastrangelo, M. J., Shields, J. A., Shields, C. L., Croce, C. M., & Huebner, K. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960315)65:6<762::aid-ijc9>3.0.co;2-x · Cited by 96
Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
Flores, J. F., Pollock, P. M., Walker, G. J., Glendening, J. M., Lin, A. H.-T., Palmer, J. M., Walters, M. K., Hayward, N. K., & Fountain, J. W. (1997) · Oncogene · doi:10.1038/sj.onc.1201470 · Cited by 84
Selective deletion of exon 1β of thep19ARF gene in metastatic melanoma cell lines
Kumar, R., Sauroja, I., Punnonen, K. R. A., Jansén, C. T., & Hemminki, K. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199811)23:3<273::aid-gcc11>3.0.co;2-n · Cited by 82
Incidence of p14ARF gene deletion in high-grade adult and pediatric astrocytomas
Newcomb, E. W., Alonso, M., Sung, T., & Miller, D. C. (2000) · Human Pathology · doi:10.1016/s0046-8177(00)80207-5 · Cited by 82
CDKN2a/p16INK4a Mutations and Lack of p19ARF Involvement in Familial Melanoma Kindreds
Fargnoli, M. C., Chimenti, S., Peris, K., Keller, G., Soyer, H. P., Pozzo, V. D., & Höfler, H. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00412.x · Cited by 80
A familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma
Kaufman, D. K., Kimmel, D. W., Parisi, J. E., & Michels, V. V. (1993) · Neurology · doi:10.1212/wnl.43.9.1728 · Cited by 80
Investigation of germline PTEN, p53, p16INK4A/p14ARF, and CDK4 alterations in familial glioma
Tachibana, I., Smith, J. S., Sato, K., Hosek, S. M., Kimmel, D. W., & Jenkins, R. B. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000515)92:2<136::aid-ajmg11>3.0.co;2-s · Cited by 74
Mutation testing in melanoma families: INK4A, CDK4 and INK4D
Newton‐Bishop, J., Harland, M., Bennett, D. C., Bataille, V. A., Goldstein, A. M., Tucker, M. A., Ponder, B. A. J., Cuzick, J. M., Selby, P., & Bishop, D. T. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690354 · Cited by 61
Liu, L., Goldstein, A. M., Tucker, M. A., Brill, H., Gruis, N. A., Hogg, D., & Lassam, N. J. (1997) · Genes Chromosomes and Cancer · Cited by 44
A cell cycle regulator potentially involved in genesis of many tumour types
Kamb, A. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90162-7 · Cited by 39
(1998) · doi:10.1002/(sici)1098-1004(1998)11:6
Cited by
Malignant glioma: genetics and biology of a grave matter
Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D. H., Louis, D. N., Cavenee, W. K., & DePinho, R. A. (2001) · Genes & Development · doi:10.1101/gad.891601 · Cited by 1,229
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009
Genome-wide association study identifies five susceptibility loci for glioma
Shete, S., Hosking, F. J., Robertson, L. B., Dobbins, S. E., Sanson, M., Malmer, B., Simon, M., Marie, Y., Boisselier, B., Delattre, J.-Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.407 · Cited by 788
Epidermal growth factor receptor and Ink4a/Arf
Bachoo, R. M., Maher, E. A., Ligon, K. L., Sharpless, N. E., Chan, S. S., You, M. J., Tang, Y., DeFrances, J., Stover, E., Weissleder, R., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00046-6 · Cited by 652
Pasmant, E., Laurendeau, I., Héron, D., Vidaud, M., Vidaud, D., & Bièche, I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2004 · Cited by 618
Metadata
- Authors
- Randerson-Moor, J. A.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01-01
- Volume
- 10
- Issue
- 1
- Pages
- 55-62
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2122889044
- Cited by
- 281
- References
- 32
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.